Literature DB >> 19647144

Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control impairments.

Jennifer M Glass1.   

Abstract

Clinical and laboratory evidence confirm that dyscognition is a real and troubling symptom in fibromyalgia (FM), and that the cognitive mechanisms most affected in FM are working memory, episodic memory, and semantic memory. Recent evidence provides further convergence on specific difficulty with attentional control. Dyscognition in FM cannot be attributed solely to concomitant psychiatric conditions such as depression and poor sleep, but does seem to be related to the level of pain. This article presents recent contributions regarding the etiology of the cognitive dysfunction, its impact on patients, and highlights the need for further research on this facet of FM.

Entities:  

Mesh:

Year:  2009        PMID: 19647144     DOI: 10.1016/j.rdc.2009.06.002

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  53 in total

1.  Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia.

Authors:  Jennifer M Glass; David A Williams; Maria-Luisa Fernandez-Sanchez; Anson Kairys; Paloma Barjola; Mary M Heitzeg; Daniel J Clauw; Tobias Schmidt-Wilcke
Journal:  J Pain       Date:  2011-09-25       Impact factor: 5.820

2.  Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity.

Authors:  Vitaly Napadow; Lauren LaCount; Kyungmo Park; Sawsan As-Sanie; Daniel J Clauw; Richard E Harris
Journal:  Arthritis Rheum       Date:  2010-08

Review 3.  Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy.

Authors:  Xiao-Min Wang; Brian Walitt; Leorey Saligan; Agnes F Y Tiwari; Chi Wai Cheung; Zhang-Jin Zhang
Journal:  Cytokine       Date:  2015-01-05       Impact factor: 3.861

4.  Toward development of a fibromyalgia responder index and disease activity score: OMERACT module update.

Authors:  Philip J Mease; Daniel J Clauw; Robin Christensen; Leslie J Crofford; R Michael Gendreau; Susan A Martin; Lee S Simon; Vibeke Strand; David A Williams; Lesley M Arnold
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

Review 5.  Monotherapy or combination therapy for fibromyalgia treatment?

Authors:  Elena Pita Calandre; Fernando Rico-Villademoros; Carmen María Rodríguez-López
Journal:  Curr Rheumatol Rep       Date:  2012-12       Impact factor: 4.592

Review 6.  Fibrofog and fibromyalgia: a narrative review and implications for clinical practice.

Authors:  Howard M Kravitz; Robert S Katz
Journal:  Rheumatol Int       Date:  2015-01-13       Impact factor: 2.631

Review 7.  Meta-analysis of cognitive performance in fibromyalgia.

Authors:  Tyler Bell; Zina Trost; Melissa T Buelow; Olivio Clay; Jarred Younger; David Moore; Michael Crowe
Journal:  J Clin Exp Neuropsychol       Date:  2018-02-01       Impact factor: 2.475

8.  Effects of milnacipran on neurocognition, pain, and fatigue in fibromyalgia: a 13-week, randomized, placebo-controlled, crossover trial.

Authors:  Jeong Lan Kim; Shilpa Rele; David M Marks; Prakash S Masand; Pallavi Yerramsetty; Robert A Millet; Richard S Keefe; Ashwin A Patkar
Journal:  Prim Care Companion CNS Disord       Date:  2014-12-26

9.  Research to encourage exercise for fibromyalgia (REEF): use of motivational interviewing, outcomes from a randomized-controlled trial.

Authors:  Dennis C Ang; Anthony S Kaleth; Silvia Bigatti; Steven A Mazzuca; Mark P Jensen; Janna Hilligoss; James Slaven; Chandan Saha
Journal:  Clin J Pain       Date:  2013-04       Impact factor: 3.442

Review 10.  Cognitive impairment in fibromyalgia.

Authors:  Paulo Henrique Ferreira Bertolucci; Fabricio Ferreira de Oliveira
Journal:  Curr Pain Headache Rep       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.